Numbers

The Numbers

Synchrony trades at roughly 8x trailing earnings while compounding tangible book per share at double-digit rates and retiring 39% of its float since the 2021 peak. The single metric most likely to re-rate the stock is the NIM-minus-NCO spread — it has widened from 8.4% (FY24) to 10.1% (Q1 FY26), and the market is still paying a multiple that assumes it will compress again. The bear case is credit normalization has not yet finished; the bull case is the earnings power you are buying is normalized, not peak, because an 84% deposit-funded spread business with a ~30% efficiency ratio does not lose its cost moat at the bottom of the cycle.

Snapshot

Quality scorecard — is this durable?

A spread business with 84% deposit funding, a 13.4% CET1 ratio, and a 24.5% return on tangible equity is structurally higher quality than the headline "private-label credit" label suggests. The signals that matter for durability are the funding mix (stable), the capital ratio (accretive), and the share count (shrinking fast). SYF fails on only one Buffett-style screen — earnings volatility, which is inherent to the credit cycle.

Earnings power — the cycle compressed into four years

Net interest income has grown ~26% since FY21 as the book has scaled from $80B to $105B. But net income tells the real story: it fell 47% from the 2021 stimulus-driven peak to the 2023 provision trough, then rebounded 56% in a single year as the provision cycle normalized. This is what a cyclical spread business looks like — top-line steady, bottom-line whippy.

The gap between NII and net income is almost entirely provision for credit losses, which swelled from $2.7B in FY21 (pandemic reserve release) to $6.7B in FY24. Operating expense growth has been the opposite of credit — nearly flat in dollar terms, producing the 30% efficiency ratio that is the quiet second moat after the deposit funding base.

The risk-adjusted spread (NIM minus NCO) bottomed at 8.45% in FY24 and is widening back toward 10%+ — if that trajectory holds through FY26, this is roughly a $10 EPS business being priced at 8x.

Quarterly trajectory — the turn

The quarterly series is where the cycle turn is visible. Normalize out the Q1 FY24 $1.04B Pets Best divestiture gain and provision has been falling for four straight quarters while net interest income is flat-to-up. That is the operating leverage re-engaging.

Adjusted quarterly earnings bottomed at $624M in 2Q24 and have since rebounded to $700M–$1.0B per quarter. The pattern is the familiar post-recession credit normalization — provision was front-loaded in FY24 under the lifetime-loss reserve model, and the reversal is feeding directly to the bottom line.

Balance sheet and funding mix — the cost moat

What makes Synchrony underrated vs a pure monoline card issuer is the funding structure: $82B of Synchrony Bank retail deposits fund an 85% earning-asset base of credit card receivables. That gap — ~4% deposit cost against ~21% portfolio yield — is the core economic engine. Competitors without an FDIC-insured bank have to fund with wholesale debt at 6–7%.

The CET1 chart is a near-perfect illustration of the capital-return playbook: SYF over-capitalized after the 2021 recovery (16.1%), then spent the last four years running the ratio back down to ~13% via buybacks while the regulatory minimum sits near 11%. Basel III standardized-approach adoption freed an estimated 125–150 bp of additional capital, which is funding the ongoing repurchase.

Capital return — the single clearest story

Since the 2021 peak, Synchrony has retired 221 million shares, or roughly 39% of the float — one of the most aggressive buyback programs in financials. At current prices, the program returns on the order of $3–4B annually in combined buybacks and dividends against a $27B market cap — a total shareholder yield in the low-teens if maintained.

Capital return accelerated dramatically in FY25 — the estimated $3.5B deployed is more than double FY24 — reflecting CET1 headroom plus management's view that the stock is below fair value. The dividend ($1.00 per share annualized) is deliberately small; buybacks do all the heavy lifting because EPS growth is the preferred metric internally.

Valuation — the most important chart

This is the one that matters. Synchrony has traded between 5x and 12x earnings for its entire public history. The trailing multiple sits near the 10-year average of ~8.5x. At 8x today, the stock is NOT cheap on a trough-cycle basis — but it is being valued as if FY26 earnings of $9+ are the peak, not the mid-cycle run-rate.

The valuation tension. Price is near a post-spin high, P/E sits near the 10-year average, yet EPS is still ramping as the provision cycle normalizes. If you believe the $9.10–9.50 FY26 guide, the forward P/E is 8.2–8.5x — exactly at the long-run mean, with an additional tailwind from share count that nobody else has. That is the case for further upside without any multiple expansion.

Peer comparison — where SYF sits

Among consumer credit specialists, SYF has the widest NIM, the lowest efficiency ratio, and competitive capital return. It trades at the low end of the P/E range with Bread (BFH) — both are private-label heavy, both cyclical — but Synchrony's scale advantage produces a 24.5% ROTCE versus Bread's 19%.

The scatter makes the mispricing visible: SYF and DFS both cluster near 22–24% ROTCE, but DFS trades at 10.5x while SYF trades at 8x. Part of this is merger-related — DFS has a pending deal with COF that adds a takeout premium. Stripping that, the two should trade closer together. BFH and OMF are the "cheap for a reason" cohort with structurally weaker franchises.

Fair value scenarios

Three cases built around FY26 EPS and exit multiple, with tangible book per share as the downside floor.

What matters from here

Three data points will determine whether this is an 8x-forever value trap or a multi-year compounder.

1. NCO cadence through 2H FY26. A move under 5% signals the cycle is done; a spike back above 6% re-scores the 8x multiple.
2. Payment rate direction. Currently 16.3% (up 110 bp vs pre-COVID). If it breaks down, consumer stress has returned; if it stays elevated, the book is structurally de-risking.
3. Capital return pace. The current $3–4B annualized buyback at a sub-10x multiple is the single biggest lever on EPS. A slowdown would imply management sees the stock as no longer cheap; an acceleration is a tell.

Under a normalized view — risk-adjusted spread at 9.5%, 340M shares, high-teens ROTCE — this is an $11 EPS business within two years. At a below-average 9x multiple, that is roughly $99 per share. The path from here is arithmetic, not heroic.